For: | Pal P, Palui R, Ray S. Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. World J Hepatol 2021; 13(11): 1584-1610 [PMID: 34904031 DOI: 10.4254/wjh.v13.i11.1584] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i11/1584.htm |
Number | Citing Articles |
1 |
Xiulu Guan, Shiyuan Shen, Jinxia Liu, Hongru Song, Jinhua Chang, Xiaoxia Mao, Jingyu Song, Lin Zhang, Cuizhe Liu. Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03903-2
|
2 |
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, Jingxuan Quek, Jie Ning Yong, Phoebe Tay, Darren Jun Hao Tan, Wen Hui Lim, Snow Yunni Lin, Daniel Huang, Mark Chan, Chin Meng Khoo, Nicholas W S Chew, Apichat Kaewdech, Naichaya Chamroonkul, Yock Young Dan, Mazen Noureddin, Mark Muthiah, Mohammed Eslam, Cheng Han Ng. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. The Journal of Clinical Endocrinology & Metabolism 2022; 107(9): 2691 doi: 10.1210/clinem/dgac321
|
3 |
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
|
4 |
Chengyuan Sun, Yan Guo, Peixu Cong, Yuan Tian, Xiang Gao. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice. Nutrients 2023; 15(6): 1359 doi: 10.3390/nu15061359
|
5 |
Carlos J Pirola, Silvia Sookoian. Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making. Expert Review of Gastroenterology & Hepatology 2023; 17(4): 317 doi: 10.1080/17474124.2023.2191190
|
6 |
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023; doi: 10.7759/cureus.45884
|
7 |
Hyun-Ju Park, Juyoung Choi, Hyunmi Kim, Da-Yeon Yang, Tae Hyeon An, Eun-Woo Lee, Baek-Soo Han, Sang Chul Lee, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Cellular heterogeneity and plasticity during NAFLD progression. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1221669
|
8 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
9 |
Olufunto O. Badmus, Zachary A. Kipp, Evelyn A. Bates, Alexandre A. da Silva, Lucy C. Taylor, Genesee J. Martinez, Wang-Hsin Lee, Justin F. Creeden, Terry D. Hinds, David E. Stec. Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2023; 325(1): R81 doi: 10.1152/ajpregu.00057.2023
|
10 |
Kun-Lin Cheng, Shao-Wen Wang, Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao. Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease. Journal of the Formosan Medical Association 2023; doi: 10.1016/j.jfma.2023.07.010
|
11 |
Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications. Hepatology International 2023; 17(2): 350 doi: 10.1007/s12072-022-10449-x
|
12 |
Line Ravndal, Katrine P. Lindvig, Ellen L. Jensen, Anita Sunde, Damoun Nassehi, Maja Thiele, Aleksander Krag, Svein Kjosavik. Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 985 doi: 10.1080/17474124.2023.2255522
|
13 |
Helaina E. Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, Jean A. Welsh, Miriam B. Vos. The Impact and Burden of Dietary Sugars on the Liver. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000297
|
14 |
Marcin Kosmalski, Izabela Szymczak-Pajor, Józef Drzewoski, Agnieszka Śliwińska. Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T CAT Polymorphism. Cells 2023; 12(18): 2228 doi: 10.3390/cells12182228
|
15 |
Nuria Perez-Diaz-del-Campo, Diego Martínez-Urbistondo, Elisabetta Bugianesi, J. Alfredo Martínez. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine. Current Opinion in Clinical Nutrition & Metabolic Care 2022; 25(5): 285 doi: 10.1097/MCO.0000000000000849
|
16 |
Mirolyuba Ilieva, James Dao, Henry E. Miller, Jens Hedelund Madsen, Alexander J. R. Bishop, Sakari Kauppinen, Shizuka Uchida. Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease. Non-Coding RNA 2022; 8(4): 56 doi: 10.3390/ncrna8040056
|
17 |
Kai En Chan, Cheng Han Ng, Clarissa Elysia Fu, Jingxuan Quek, Gwyneth Kong, Yi Jie Goh, Rebecca Wenling Zeng, Michael Tseng, Manik Aggarwal, Benjamin Nah, Douglas Chee, Zhen Yu Wong, Sitong Zhang, Jiong-Wei Wang, Nicholas W.S. Chew, Yock Young Dan, Mohammad Shadab Siddiqui, Mazen Noureddin, Arun J. Sanyal, Mark Muthiah. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals. Clinical Gastroenterology and Hepatology 2023; 21(10): 2560 doi: 10.1016/j.cgh.2022.09.028
|
18 |
Gino A. Kurian, Bhavana Sivakumar. Phospholipases in Physiology and Pathology. 2023; : 3 doi: 10.1016/B978-0-443-15177-4.00007-8
|